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ABSTRACT 
The effects of Albendazole and Triclabendazole on 12 adult Pelibuey ovines infected by Fasciola hepatica in the 
province of Camagüey, Cuba, were evaluated. A reduction and fecal egg count test was performed. Two groups of 
animals were made for critical study. On day 0 (D0), the animals in group 1 were given Albendazole orally, and 
group 2 received Triclabendazole. The fecal samples were collected (rectal) on days 0 (D0), 14 (D14), and 28 (D28), 
after treatment. The McMaster technique was used for F. hepatica egg count using a ZnCl2 solution (1.5 g/ml), at 10 
eggs per stool gram. The groupʼs mean results first, and the egg reduction per cent later, were calculated. On D14, 
98.17 % egg reduction was observed in group 1, and 79.58 % in group 2. However, on D28, group 1 underwent 33 % 
reduction, whereas group 2 experienced 90.39 %. The treatment using Triclabendozole was more effective for F. he-
patica. 
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INTRODUCTION  
Fasciolosis is a parasite infection that mainly af-
fects bovines, ovines, caprines, and humans 
(Fairweather, 2011). The disease varies notably, 
depending on the geographical areas. These para-
sites can live throughout the year if factors like 
agricultural development, nutritional deficiencies, 
grass height, immune and nutritional status of the 
final host, presence of the middle host, and existing 
infecting forms in the environment, are favorable. 
Several negative effects by Fasciola hepatica 
have been reported in Cuba on bovines and 
ovines. It was the most widespread disease during 
a five-year period, causing huge economic losses 
in central Cuba (Reinaldo, 2002), according to 
slaughterhouse records, and seized livers (Ido, 
2002). 
Animal production in Cuba is hampered, among 
other causes, by this trematode. Accordingly, new 
strategies to control Fasciola hepatica are essen-
tial to increase livestock production. It is impor-
tant to know the efficacy of antiparasitic medica-
tion before application in herds. To control 
parasite infection, Albendazole and Triclabenda-
zole (Keyser et al., 2009), were used. The purpose 
of this study is to evaluate the efficacy of Alben-
dazole and Triclabendazole on ovines infected na-
turally by F. hepatica. 
MATERIALS AND METHODS 
A critical test was made on a farm near the Uni-
versity of Camagüey, Cuba, according to the 
World Association for the Advancement of Vete-
rinary Parasitology (WAAVP) Guidelines (Lyons 
et al., 1996). As part of the test, twelve adult Peli-
buey bovines were split in two groups. On day 0 
(D0), the animals in group 1 were given 10 mg/kg 
of Albendazole orally; the animals in group 2 re-
ceived 10 mg/kg of Triclabendazole. Fecal egg 
count reduction test (HPG) was made. Rectal 
samples were collected on days 0 (D0), 14 (D14), 
and 28 (D28), after the treatment. The McMaster 
technique was used for F. hepatica egg count using 
a ZnCl2 solution (1.5 g/ml), at 10 eggs per stool 
gram. Calculations were made of the group/stage 
mean results, first, and then the egg reduction per 
cent. Graph Prism software was used for statistical 
analysis. Simple ANOVA was performed, and the 
groupʼs mean difference was determined by the 
Student Newman-Keuls Multiple Comparison 
test.  
RESULTS AND DISCUSSION 
On D14, 98.17 % egg reduction was observed 
for group 1 (Albendazole), and 79.58 % for 
group 2 (Triclabendazole). However, on D28, 
group 2 had 90.39 % egg reduction; whereas 
group 2 showed 33 % (see Figure). These results 
are similar to a study made by Stojevic et al. 
(2005), in Bolivia. The treatment with Triclaben-
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dazole ensured more than 90 % egg reduction in 
weeks 2-8 after the treatment (P < 0.05), but drug 
resistance was clearly observed for Albendazole, 
as egg reduction was below 50 % in the weeks 
following the treatment. In the second 
herd,anthelmintic resistance to Triclabendazole 
was observed, with less than 65 % oviposition af-
ter treatment; whereas in the group treated with 
Albendazole, oviposition decreased less than 
60 % in the first 4 weeks after the treatment. 
However, no differences were observed in week 7 
in terms of oviposition in the control group (La-
verde, 2007). One sheep in the control group of 
the second herd was sacrificed in week 7, due to 
severe acute Fasciolosis, but the animal data were 
not considered, including Fasciola counts. 
So far, there are no resistant reports of Fasciola 
hepatica in Cuba. Over evaluation of this studyʼs 
efficacy, on D14, Triclabendazole had lower Fas-
ciolitic activity (P < 0.05) than Albendazole. It 
was different on D28, because Triclabendazole 
was significantly more efficient. Another study 
reported that Triclabendazole was very active aga-
inst adult and immature forms of the trematode 
(Fairweather, 2005), making it the the most wi-
dely used medication to control fasciolosis. How-
ever, the loss of efficacy of Triclabendazole may 
occur under certain circumstances, mainly due to 
the wrong treatment or inadequate dose adminis-
tration by farmers, without specialized veterinary 
assistance (Ortiz et al., 2011). Internationally, a 
steady increase in anthelmintic resistance has 
been observed in ruminating livestock; hence, 
new preparations must be tested with the already 
existing medication (Boray et al., 1983; Fair-
weather, 2005). However, in Cuba there are no 
reports on resistance. Albendazole resistance by 
ovine parasites has been reported in New Zealand 
(Leathwick et al., 2006; Waghorn et al., 2006). In 
Chile, Australia, and the Netherlands Triclaben-
dazole resistance has been reported for Fasciola 
hepatica (Laverde, 2007; Overend and Bowen, 
1995; Moll et al., 2000; Gaasenbeek et al., 2001).  
Other studies in Bolivia (Villegas, 2012) also 
showed the efficacy of Triclabendazol against F. 
hepatica, using 10 mg/kg of Albendazole and 
10 mg/kg of Triclabendazole orally. The animals 
in the study remained in their grasslands. In this 
study, the same or similar doses used by Mezo et 
al. (2004); Mezo et al. (2008); Flanagan et al. 
(2011) were used. The animals also remained in 
the grasslands; efficacy was observed. Moreover, 
Albendazole was effective to control F. hepatica, 
only to D14. However, the presence of immature 
trematodes at the time of parasite disinfection 
must not be excluded as the cause for an increase 
in the number of eggs on D28. Albendazole is a 
fasciolicide that acts only against adult trematodes 
(Buchanan et al., 2003), besides being a nemati-
cide. F. hepatica eggs are known to be freed un-
evenly in the stools, with a high level of variabili-
ty (Fairweather, 2011), which may also alter 
HPG. 
CONCLUSIONS 
Triclabendazole was efficacious against F. he-
patica over a longer period than Albendazole. 
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Evaluated groups: G1 Albendazole, G2 Triclabendazole  
Daily treatment: D0, day 14 (D14), and day 28 (D28) (P < 0.05), Test of Multiple Comparison  
Figure. Number of eggs per stool gram (HPG) after treatment with Albendazole ad Triclabendazole in adult 
sheep 
